Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle

被引:0
作者
Xujie Zhuang
Bo Liu
Junqi Long
Huina Wang
Jiangyong Yu
Xinchan Ji
Jinmeng Li
Nian Zhu
Lujia Li
Yuhaoran Chen
Zhidong Liu
Shuangtao Zhao
机构
[1] Beijing University of Technology,School of Software Engineering, Faculty of Information Technology
[2] Massey University,School of Mathematical and Computational Sciences
[3] Chinese Academy of Medical Sciences,Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine
[4] Capital Medical University,Department of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital
[5] Capital Medical University,Department of Breast Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital
来源
Clinical and Translational Oncology | 2024年 / 26卷
关键词
Diffuse large B-cell lymphoma; Molecular subgroup; Machine learning; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:936 / 950
页数:14
相关论文
共 177 条
[1]  
Reddy A(2017)Genetic and functional drivers of diffuse large B cell lymphoma Cell 171 481-494
[2]  
Zhang J(2021)Lower survival and increased circulating suppressor cells in patients with relapsed/refractory diffuse large B-cell lymphoma with deficit of vitamin D levels using R-GDP plus lenalidomide (R2-GDP): results from the R2-GDP-GOTEL trial Cancers (Basel) 13 4622-511
[3]  
Davis NS(2021)Whole Transcriptome data analysis reveals prognostic signature genes for overall survival prediction in diffuse large B cell lymphoma Front Genet 12 963-1237
[4]  
Moffitt AB(2017)Genetic and functional drivers of diffuse large B cell lymphoma Cell 171 503-829
[5]  
Love CL(2000)Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 1229-315
[6]  
Waldrop A(2016)Promising novel agents for aggressive B-cell lymphoma Hematol Oncol Clin N Am 30 397-1573
[7]  
Jiménez-Cortegana C(2021)CHN1 is a novel prognostic marker for diffuse large B-cell lymphoma Pharmacogn Pers Med 14 814-15550
[8]  
Sánchez-Martínez PM(2022)Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes? Br J Haematol 196 307-1740
[9]  
Palazón-Carrión N(2004)affy—analysis of Affymetrix GeneChip data at the probe level Bioinformatics 20 1572-287
[10]  
Nogales-Fernández E(2010)ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking Bioinformatics 26 e47-33